{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:30:19Z","timestamp":1793424619589,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.mayocp.2014.05.013","type":"journal-article","created":{"date-parts":[[2014,9,2]],"date-time":"2014-09-02T01:18:41Z","timestamp":1409620721000},"page":"1287-1306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":372,"title":["Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology"],"prefix":"10.1016","volume":"89","author":[{"given":"Joerg","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole P.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector R.","family":"Villarraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Mulvagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Kohli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","article-title":"The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin\u2019s disease: University of Minnesota experience","volume":"48","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"23","key":"10.1016\/j.mayocp.2014.05.013_bib2","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","article-title":"Cardiac complications of thoracic irradiation","volume":"61","author":"Jaworski","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdq609","article-title":"Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper","volume":"22","author":"Aapro","year":"2011","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.05.013_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/annonc\/mdr348","article-title":"Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors","volume":"23","author":"Serrano","year":"2012","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.mayocp.2014.05.013_bib5","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1093\/annonc\/mds127","article-title":"Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis","volume":"23","author":"Tarantini","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.mayocp.2014.05.013_bib6","first-page":"126","article-title":"Cardio-oncology: a new medical issue","volume":"2","author":"Cardinale","year":"2008","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"24","key":"10.1016\/j.mayocp.2014.05.013_bib8","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","article-title":"Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management","volume":"53","author":"Yeh","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0277-5379(84)90215-3","article-title":"Mitoxantrone in advanced breast cancer\u2014a phase II study with special attention to cardiotoxicity","volume":"20","author":"Coleman","year":"1984","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.05.013_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","article-title":"Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention","volume":"22","author":"Pai","year":"2000","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib11","first-page":"55","article-title":"Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimen","volume":"8","author":"Cerny","year":"2009","journal-title":"Clin Colorectal Cancer"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/annonc\/mdr294","article-title":"Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab","volume":"23","author":"Lenihan","year":"2012","journal-title":"Ann Oncol"},{"issue":"25","key":"10.1016\/j.mayocp.2014.05.013_bib13","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","article-title":"Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0025-6196(11)60896-3","article-title":"Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials","volume":"83","author":"Perez","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"9604","key":"10.1016\/j.mayocp.2014.05.013_bib15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0140-6736(07)61865-0","article-title":"Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib","volume":"370","author":"Chu","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mayocp.2014.05.013_bib16","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/annonc\/mdp025","article-title":"Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis","volume":"20","author":"Di Lorenzo","year":"2009","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2014.05.013_bib17","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/annonc\/mdn168","article-title":"Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate","volume":"19","author":"Telli","year":"2008","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jchf.2012.09.001","article-title":"The frequency and severity of cardiovascular toxicity from targeted therapy in advanced renal cell carcinoma patients","volume":"1","author":"Hall","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1303989","article-title":"Pazopanib versus sunitinib in metastatic renal-cell carcinoma","volume":"369","author":"Motzer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mayocp.2014.05.013_bib20","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T","article-title":"Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon: an unexpectedly frequent complication","volume":"74","author":"Kruit","year":"1994","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.mayocp.2014.05.013_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/JTO.0b013e3181e2f7fb","article-title":"A\u00a0multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung","volume":"5","author":"Leighl","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib22","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.ophtha.2012.02.010","article-title":"One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema","volume":"119","author":"Do","year":"2012","journal-title":"Ophthalmology"},{"issue":"13","key":"10.1016\/j.mayocp.2014.05.013_bib23","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1200\/JCO.2005.05.827","article-title":"Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity","volume":"23","author":"Ewer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.mayocp.2014.05.013_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1532-429X-10-5","article-title":"Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy","volume":"10","author":"Fallah-Rad","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.hfc.2011.03.003","article-title":"Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy","volume":"7","author":"Sawaya","year":"2011","journal-title":"Heart Fail Clin"},{"issue":"Suppl 7","key":"10.1016\/j.mayocp.2014.05.013_bib27","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines","volume":"23","author":"Curigliano","year":"2012","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib28","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2002.20.5.1215","article-title":"Cardiac dysfunction in the trastuzumab clinical trials experience","volume":"20","author":"Seidman","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.mayocp.2014.05.013_bib29","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1388-9842(00)00141-0","article-title":"More \u2018malignant\u2019 than cancer? Five-year survival following a first admission for heart failure","volume":"3","author":"Stewart","year":"2001","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib31","first-page":"955","article-title":"Overview of cardiac pathology in relation to anthracycline cardiotoxicity","volume":"62","author":"Ferrans","year":"1978","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-125-1-199607010-00008","article-title":"Anthracycline-induced cardiotoxicity","volume":"125","author":"Shan","year":"1996","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2014.05.013_bib33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/pbc.20346","article-title":"Pathology of radiation and anthracycline cardiotoxicity","volume":"44","author":"Berry","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1096\/fasebj.13.2.199","article-title":"Role of iron in anthracycline cardiotoxicity: new tunes for an old song?","volume":"13","author":"Minotti","year":"1999","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12012-007-0009-1","article-title":"Role of mtDNA lesions in anthracycline cardiotoxicity","volume":"7","author":"Lebrecht","year":"2007","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced oxidative mitochondrial cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol Toxicol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib37","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/CIRCRESAHA.113.300218","article-title":"Emerging paradigms in cardiomyopathies associated with cancer therapies","volume":"113","author":"Ky","year":"2013","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib39","first-page":"330","article-title":"Fulminant fatal cardiotoxicity following cyclophosphamide therapy","volume":"54","author":"Katayama","year":"2009","journal-title":"J\u00a0Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib40","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","article-title":"Cardiotoxicity associated with high-dose cyclophosphamide therapy","volume":"141","author":"Gottdiener","year":"1981","journal-title":"Arch Intern Med"},{"issue":"9690","key":"10.1016\/j.mayocp.2014.05.013_bib41","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0140-6736(08)60552-8","article-title":"Cardiotoxicity associated with sunitinib","volume":"371","author":"Hariharan","year":"2008","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.mayocp.2014.05.013_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nrcardio.2010.121","article-title":"Cardiotoxicity of anticancer treatments: what the cardiologist needs to know","volume":"7","author":"Ewer","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1752-8062.2008.00090.x","article-title":"Sunitinib-induced cardiotoxicity is mediated by off-target inhibition of AMP-activated protein kinase","volume":"2","author":"Kerkela","year":"2009","journal-title":"Clin Transl Sci"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11906-011-0225-8","article-title":"Heart failure associated with sunitinib: lessons learned from animal models","volume":"13","author":"Greineder","year":"2011","journal-title":"Curr Hypertens Rep"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib45","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.107.690487","article-title":"Role of neuregulin-1\/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure","volume":"116","author":"Lemmens","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nm0502-459","article-title":"ErbB2 is essential in the prevention of dilated cardiomyopathy","volume":"8","author":"Crone","year":"2002","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1200\/JCO.2010.31.9129","article-title":"Congestive heart failure risk in patients with breast cancer treated with bevacizumab","volume":"29","author":"Choueiri","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"18","key":"10.1016\/j.mayocp.2014.05.013_bib48","doi-asserted-by":"crossref","first-page":"e560","DOI":"10.1200\/JCO.2011.35.5008","article-title":"Cardiotoxicity in patients treated with bevacizumab is potentially reversible","volume":"29","author":"Hawkes","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.mayocp.2014.05.013_bib49","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.091415198","article-title":"A\u00a0cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function","volume":"98","author":"Giordano","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"10","key":"10.1016\/j.mayocp.2014.05.013_bib50","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/eurheartj\/eht114","article-title":"Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease","volume":"35","author":"Groarke","year":"2014","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.mayocp.2014.05.013_bib52","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1200\/JCO.2010.33.4730","article-title":"High risk of symptomatic cardiac events in childhood cancer survivors","volume":"30","author":"van der Pal","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib53","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1200\/JCO.2008.20.2267","article-title":"Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer","volume":"28","author":"Tukenova","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"14","key":"10.1016\/j.mayocp.2014.05.013_bib54","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.113.001435","article-title":"Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study","volume":"127","author":"Wu","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.mayocp.2014.05.013_bib55","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib56","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0360-3016(94)00656-6","article-title":"Radiation injury to the heart","volume":"31","author":"Stewart","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ctrv.2010.12.004","article-title":"Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease","volume":"37","author":"van Leeuwen-Segarceanu","year":"2011","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.crd.0000131188.41589.c5","article-title":"Cardiovascular effects of radiation therapy: practical approach to radiation therapy-induced heart disease","volume":"13","author":"Lee","year":"2005","journal-title":"Cardiol Rev"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib59","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","article-title":"Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases","volume":"27","author":"Veinot","year":"1996","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2011.10.011","article-title":"Irradiation induced modest changes in murine cardiac function despite progressive structural damage to the myocardium and microvasculature","volume":"103","author":"Seemann","year":"2012","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.11091882","article-title":"Delayed contrast enhancement on MR images of myocardium: past, present, future","volume":"261","author":"Ordovas","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib62","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/djk064","article-title":"Long-term risk of cardiovascular disease in 10-year survivors of breast cancer","volume":"99","author":"Hooning","year":"2007","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"14","key":"10.1016\/j.mayocp.2014.05.013_bib63","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jacc.2013.01.019","article-title":"Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer","volume":"61","author":"Yl\u00e4nen","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib64","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.radonc.2012.08.002","article-title":"Local heart irradiation of ApoE(\u2212\/\u2212) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis","volume":"105","author":"Gabriels","year":"2012","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.radonc.2012.11.001","article-title":"Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL\/6J and atherosclerosis-prone ApoE(\u2212\/\u2212) mice","volume":"105","author":"Hoving","year":"2012","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib66","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2353\/ajpath.2006.050409","article-title":"Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE\u2212\/\u2212 mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage","volume":"168","author":"Stewart","year":"2006","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib67","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCHEARTFAILURE.110.958454","article-title":"Radiation-induced heart disease","volume":"4","author":"O H-Ic\u00ed","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.mayocp.2014.05.013_bib68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-2-13","article-title":"A\u00a0comparison of mantle versus involved-field radiotherapy for Hodgkin\u2019s lymphoma: reduction in normal tissue dose and second cancer risk","volume":"2","author":"Koh","year":"2007","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"63","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib70","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2013.01.017","article-title":"Ionising radiation induces persistent alterations in the cardiac mitochondrial function of C57BL\/6 mice 40 weeks after local heart exposure","volume":"106","author":"Barjaktarovic","year":"2013","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2014.05.013_bib71","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1161\/CIRCULATIONAHA.113.002271","article-title":"Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans","volume":"128","author":"Yu","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mayocp.2014.05.013_bib72","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/01.ATV.0000233387.90257.9b","article-title":"Angiogenesis in atherogenesis","volume":"26","author":"Herrmann","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.mayocp.2014.05.013_bib73","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jacc.2009.11.053","article-title":"Understanding radiation-induced vascular disease","volume":"55","author":"Weintraub","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib74","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2796.2011.02353.x","article-title":"Cardiovascular disease associated with radiotherapy: activation of nuclear factor kappa-B","volume":"269","author":"Halle","year":"2011","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib75","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cardiores.2006.03.002","article-title":"DNA damage and repair in atherosclerosis","volume":"71","author":"Mahmoudi","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.mayocp.2014.05.013_bib76","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.amjcard.2013.08.026","article-title":"Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity","volume":"112","author":"Lotrionte","year":"2013","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib77","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12350-013-9707-1","article-title":"Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively","volume":"20","author":"Schwartz","year":"2013","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"4 Pt 1","key":"10.1016\/j.mayocp.2014.05.013_bib78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/0002-8703(83)90080-7","article-title":"Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance","volume":"106","author":"Choi","year":"1983","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib79","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM197902083000603","article-title":"Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography","volume":"300","author":"Alexander","year":"1979","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib80","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0002-9343(87)90212-9","article-title":"Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy: seven-year experience using serial radionuclide angiocardiography","volume":"82","author":"Schwartz","year":"1987","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib81","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.echo.2013.12.005","article-title":"Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhanced and contrast-enhanced two-dimensional and three-dimensional echocardiography","volume":"27","author":"Hoffmann","year":"2014","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib82","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0929-8266(00)00077-X","article-title":"Evaluation of left ventricular systolic function by 3D echocardiography: a comparative study with X-ray angiography and radionuclide angiography","volume":"11","author":"Eder","year":"2000","journal-title":"Eur J Ultrasound"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib84","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1053\/euhj.2000.2011","article-title":"Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable?","volume":"21","author":"Bellenger","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mayocp.2014.05.013_bib85","article-title":"Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography","author":"Fine","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib86","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.mayocp.2014.05.013_bib87","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","article-title":"Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction","volume":"25","author":"Poterucha","year":"2012","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"22","key":"10.1016\/j.mayocp.2014.05.013_bib88","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2010.11.063","volume":"57","author":"Fallah-Rad","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.mayocp.2014.05.013_bib89","unstructured":"Xu YH J, Pellikka P, Ansell S, Cha S, HR V. Early changes in 2D-speckle tracking echocardiography may predict a decrease in left ventricular ejection fraction in lymphoma patients undergoing anthracycline chemotherapy. J Am Soc Echocardiogr. 2013;26(6):B52."},{"issue":"12","key":"10.1016\/j.mayocp.2014.05.013_bib90","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ejechocard\/jer187","article-title":"Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy","volume":"12","author":"Stoodley","year":"2011","journal-title":"Eur J Echocardiogr"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib91","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.bjc.6600346","article-title":"Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients","volume":"86","author":"Nousiainen","year":"2002","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2014.05.013_bib92","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0735-1097(00)00748-8","article-title":"Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy","volume":"36","author":"Cardinale","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib93","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2013.10.061","article-title":"Early increases in multiple biomarkers predict subsequent cardiotoxicity in breast cancer patients treated with doxorubicin, taxanes, and trastuzumab","volume":"63","author":"Ky","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib94","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ejhf.8","article-title":"Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy","volume":"16","author":"Kang","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"25","key":"10.1016\/j.mayocp.2014.05.013_bib95","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1200\/JCO.2009.27.3615","article-title":"Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation","volume":"28","author":"Cardinale","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2014.05.013_bib96","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.echo.2013.07.005","article-title":"Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"26","author":"Lancellotti","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib97","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1200\/JCO.2006.07.0805","article-title":"Screening for coronary artery disease after mediastinal irradiation for Hodgkin\u2019s disease","volume":"25","author":"Heidenreich","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.mayocp.2014.05.013_bib98","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1200\/JCO.2006.08.6595","article-title":"Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer","volume":"25","author":"Correa","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2014.05.013_bib99","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1200\/JCO.2011.38.9304","article-title":"Breast cancer radiotherapy and coronary artery stenosis: location, location, location","volume":"30","author":"Zagar","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcmg.2013.07.013","article-title":"Impact of coronary artery calcium characteristics on accuracy of CT Angiography","volume":"7","author":"Kruk","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"17","key":"10.1016\/j.mayocp.2014.05.013_bib101","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/eurheartj\/eht488","article-title":"Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study","volume":"35","author":"Rochitte","year":"2014","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.mayocp.2014.05.013_bib102","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1200\/JCO.2004.09.109","article-title":"Cardiovascular status in long-term survivors of Hodgkin\u2019s disease treated with chest radiotherapy","volume":"22","author":"Adams","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib103","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/pbc.21289","article-title":"Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia","volume":"49","author":"Jarfelt","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"16","key":"10.1016\/j.mayocp.2014.05.013_bib104","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/annonc\/mdf132","article-title":"Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients","volume":"13","author":"Jensen","year":"2002","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2008-0137","article-title":"Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations","volume":"14","author":"Mart\u00edn","year":"2009","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib107","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MAT.0b013e3182a0d242","article-title":"Acute chemotherapy-induced cardiomyopathy treated with intracorporeal left ventricular assist device in an 8-year-old child","volume":"59","author":"Schweiger","year":"2013","journal-title":"ASAIO J"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib108","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacc.2013.09.040","article-title":"Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: outcomes from the INTERMACS Registry","volume":"63","author":"Oliveira","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10047-011-0567-7","article-title":"Successful bridge to recovery with VAD implantation for anthracycline-induced cardiomyopathy","volume":"14","author":"Kurihara","year":"2011","journal-title":"J\u00a0Artif Organs"},{"issue":"26","key":"10.1016\/j.mayocp.2014.05.013_bib110","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","article-title":"Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer","volume":"332","author":"Lipshultz","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2014.05.013_bib111","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM199103213241205","article-title":"Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood","volume":"324","author":"Lipshultz","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2014.05.013_bib112","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1200\/JCO.2005.12.121","article-title":"Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia","volume":"23","author":"Lipshultz","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2014.05.013_bib113","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/pbc.20351","article-title":"Role of afterload reduction in the prevention of late anthracycline cardiomyopathy","volume":"44","author":"Silber","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"31","key":"10.1016\/j.mayocp.2014.05.013_bib114","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1200\/JCO.2005.13.300","article-title":"Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment","volume":"23","author":"Ewer","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nrclinonc.2011.177","article-title":"Treatment of HER2-positive breast cancer: current status and future perspectives","volume":"9","author":"Arteaga","year":"2012","journal-title":"Nat Rev Clin Oncol"},{"issue":"9897","key":"10.1016\/j.mayocp.2014.05.013_bib116","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)61094-6","article-title":"2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial","volume":"382","author":"Goldhirsch","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib117","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study","volume":"14","author":"Swain","year":"2013","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2014.05.013_bib118","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/79510","article-title":"The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals","volume":"6","author":"Kureishi","year":"2000","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib119","doi-asserted-by":"crossref","first-page":"H2341","DOI":"10.1152\/ajpheart.01126.2011","article-title":"Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the transgenic (mRen2) rat","volume":"302","author":"Ma","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.mayocp.2014.05.013_bib120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2011.09.019","article-title":"Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice","volume":"101","author":"Hoving","year":"2011","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib121","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1016\/j.ijcard.2011.07.070","article-title":"Late calcification of the mitral-aortic junction causing transient complete atrio-ventricular block after mediastinal radiation of Hodgkin lymphoma: multimodal visualization","volume":"155","author":"Santoro","year":"2012","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib122","first-page":"CD003917","article-title":"Cardioprotective interventions for cancer patients receiving anthracyclines","author":"van Dalen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"23","key":"10.1016\/j.mayocp.2014.05.013_bib123","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2012.07.067","article-title":"Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy: an observational clinical cohort study","volume":"60","author":"Seicean","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib124","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.112.000055","article-title":"Cardioprotective effect of beta-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure","volume":"6","author":"Seicean","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib125","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jacc.2006.07.052","article-title":"Protective effects of carvedilol against anthracycline-induced cardiomyopathy","volume":"48","author":"Kalay","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mayocp.2014.05.013_bib126","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cardfail.2012.06.416","article-title":"Protective effect of carvedilol on adriamycin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia","volume":"18","author":"El-Shitany","year":"2012","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.mayocp.2014.05.013_bib127","doi-asserted-by":"crossref","DOI":"10.5603\/CJ.a2013.0150","article-title":"Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: a prospective randomized controlled study with 6-month follow-up","author":"Elitok","year":"2014","journal-title":"Cardiol J"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib128","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.ijcard.2012.06.023","article-title":"Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study","volume":"167","author":"Kaya","year":"2013","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib129","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/ajh.21840","article-title":"Cardioprotective effect of metoprolol and enalapril in doxorubicin-treated lymphoma patients: a prospective, parallel-group, randomized, controlled study with 36-month follow-up","volume":"85","author":"Georgakopoulos","year":"2010","journal-title":"Am J Hematol"},{"issue":"23","key":"10.1016\/j.mayocp.2014.05.013_bib130","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2013.02.072","volume":"61","author":"Bosch","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib131","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","article-title":"Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines","volume":"22","author":"Silber","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.mayocp.2014.05.013_bib132","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","article-title":"Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition","volume":"114","author":"Cardinale","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2014.05.013_bib133","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/cncr.21478","article-title":"Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisolone","volume":"104","author":"Nakamae","year":"2005","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.mayocp.2014.05.013_bib134","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3892\/etm.2011.305","article-title":"Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction","volume":"2","author":"Dessi","year":"2011","journal-title":"Exp Therap Med"},{"issue":"9","key":"10.1016\/j.mayocp.2014.05.013_bib135","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jacc.2011.05.025","article-title":"Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy","volume":"58","author":"Acar","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2014.05.013_bib136","first-page":"577","article-title":"Potentiation of the toxicity of adriamycin by propranolol","volume":"21","author":"Choe","year":"1978","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"6","key":"10.1016\/j.mayocp.2014.05.013_bib137","doi-asserted-by":"crossref","first-page":"H2441","DOI":"10.1152\/ajpheart.00005.2005","article-title":"Differential cardioprotective\/cardiotoxic effects mediated by beta-adrenergic receptor subtypes","volume":"289","author":"Bernstein","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619614004753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619614004753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:29:22Z","timestamp":1758418162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619614004753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":137,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0025619614004753"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2014.05.013","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2014.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}